Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy.

Purpose: The relevance of apoptosis to breast cancer response to chemotherapy is unclear. We investigated whether changes in tumor cell apoptosis and Bcl-2 expression immediately after chemotherapy correlated with response to breast cancer treatment.Patients and Methods: Serial core biopsies of 25 b...

Descripción completa

Detalles Bibliográficos
Publicado en:Cancer Journal Vol. 9; no. 1; pp. 33 - 34
Autores principales: Buchholz TA, Davis DW, Mcconkey DJ, Symmans WF, Valero V, Jhingran A, Tucker SL, Pusztai L, Cristofanilli M, Esteva FJ, Hortobagyi GN, Sahin AA, Buchholz, Thomas A, Davis, Darren W, McConkey, David J, Symmans, W Fraser, Valero, Vicente, Jhingran, Anuja, Tucker, Susan L, Pusztai, Lajos
Formato: research Journal Article
Publicado: Lippincott Williams & Wilkins Jan/Feb2003
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106099433&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 106099433
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        15289117
        4U5
      jtl: Cancer Journal
      issn: 15289117
      maglogo: N
    pubinfo:
      dt: Jan/Feb2003
      vid: 9
      iid: 1
      pid: 5086
      pub: Lippincott Williams & Wilkins
      place: Baltimore, Maryland
    artinfo:
      ui:
        106099433
        NLM12602766
        2009455913
        10.1097/00130404-200301000-00007
        NLM12602766
        106099433
      ppf: 33
      ppct: 1
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Chemotherapy-induced apoptosis and Bcl-2 levels correlate with breast cancer response to chemotherapy.
      aug:
        au:
          Buchholz TA
          Davis DW
          Mcconkey DJ
          Symmans WF
          Valero V
          Jhingran A
          Tucker SL
          Pusztai L
          Cristofanilli M
          Esteva FJ
          Hortobagyi GN
          Sahin AA
          Buchholz, Thomas A
          Davis, Darren W
          McConkey, David J
          Symmans, W Fraser
          Valero, Vicente
          Jhingran, Anuja
          Tucker, Susan L
          Pusztai, Lajos
        affil: Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
      sug:
        subj:
          Antineoplastic Agents, Combined Therapeutic Use
          Apoptosis Drug Effects
          Breast Neoplasms Drug Therapy
          Doxorubicin Therapeutic Use
          Hydrocarbons
          Paclitaxel Analogs and Derivatives
          Paclitaxel Therapeutic Use
          Proteins Metabolism
          Adult
          Aged
          Biopsy Methods
          Breast Neoplasms Pathology
          Breast Neoplasms Surgery
          Female
          Genetic Techniques
          Middle Age
          Neoplastic Processes Drug Therapy
          Neoplastic Processes Pathology
          Neoplastic Processes Surgery
          Predictive Value of Tests
          Prospective Studies
          Time Factors
          Tumor Markers, Biological Metabolism
          Human
          Adult: 19-44 years
          Aged: 65+ years
          Middle Aged: 45-64 years
          Female
      ab: Purpose: The relevance of apoptosis to breast cancer response to chemotherapy is unclear. We investigated whether changes in tumor cell apoptosis and Bcl-2 expression immediately after chemotherapy correlated with response to breast cancer treatment.Patients and Methods: Serial core biopsies of 25 breast cancer primary tumors were performed at either two or three time points: before treatment (N = 24) and approximately 24 hours (N = 22) and/or 48 hours (N = 19) after the initiation of the first cycle of chemotherapy. Apoptosis levels were quantified by use of a fluorescent terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling (TUNEL) stain, and Bcl-2 and Bax were measured by semiquantitative immunohistochemical assays. All calculated P values were two sided.Results: The apoptosis level at 48 hours was significantly higher in the tumors with pathological complete response or < 1 cm of residual disease (median, 22%; range, 6%-51%) than in the tumors with > 1 cm residual disease (median, 7%; range, 1%-36%); Mann-Whitney test. This difference was also present in the subgroup of 16 tumors treated with docetaxel/doxorubicin chemotherapy (25% vs 4%, respectively). A decrease in Bcl2 expression after chemotherapy relative to the expression from the pretreatment sample also correlated with disease response. Specifically, three of the nine tumors with a decrease in Bcl-2 had a pathological complete response, compared with 0 of the 15 tumors with stable levels of Bcl-2 (Fisher's exact test). There was no relationship between serial measurements of Bax and response.Discussion: These data suggest that apoptosis may play an important role in determining breast cancer response to chemotherapy and that the level of treatment-induced apoptosis may have some value as a predictive marker.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N